| Title |
ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, January 2012
|
| DOI | 10.2147/ndt.s27025 |
| Pubmed ID | |
| Authors |
Amedeo Minichino, Francesco Saverio Bersani, Enrico Capra, Rossella Pannese, Celeste Bonanno, Massimo Salviati, Roberto Delle Chiaie, Massimo Biondi |
| Abstract |
Biological treatments are considered as additional options for the treatment of resistant unipolar depression. Controversial data exist about the efficacy and tolerability of three of the most used somatic treatments: electroconvulsive therapy (ECT), transcranial magnetic stimulation (rTMS), and deep transcranial magnetic stimulation (deepTMS). The aim of this review is to investigate and compare the efficacy and tolerability of these three techniques in drug-free patients with pharmacoresistant unipolar depression. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 3 | 3% |
| Germany | 1 | 1% |
| Australia | 1 | 1% |
| Italy | 1 | 1% |
| Brazil | 1 | 1% |
| Spain | 1 | 1% |
| Unknown | 89 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 15% |
| Student > Bachelor | 14 | 14% |
| Student > Ph. D. Student | 11 | 11% |
| Student > Master | 10 | 10% |
| Other | 7 | 7% |
| Other | 21 | 22% |
| Unknown | 19 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 23 | 24% |
| Medicine and Dentistry | 23 | 24% |
| Agricultural and Biological Sciences | 10 | 10% |
| Neuroscience | 10 | 10% |
| Social Sciences | 4 | 4% |
| Other | 7 | 7% |
| Unknown | 20 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2021.
All research outputs
#7,960,693
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,035
of 3,132 outputs
Outputs of similar age
#66,833
of 250,099 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 8 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,099 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.